Loading clinical trials...
Loading clinical trials...
A Phase 1, Observer-Blind, Randomized, Active Controlled Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 To 15 Months of Age Receiving a Single Booster Dose
Conditions
Interventions
Pn-MAPS30plus
PCV20
Start Date
May 15, 2026
Primary Completion Date
February 22, 2027
Completion Date
February 22, 2027
Last Updated
February 12, 2026
NCT07428759
NCT06238297
NCT05976581
NCT03100760
NCT06602557
NCT06113432
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions